Advertising

NASDAQ:OSMT

1.13
0.00 (0.00%) 1d
0
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »
DON'T BUY
A tiny company and speculative. Some months ago, they had a tired, but profitable portfolio of generic and profitable drugs that produced a stream of cash. They invested that cash to treat droopy eyelid, with a goal to be a less-generic drug company and more branded. Then they tested an MS-related drug, but shelved it which hurt the stock. Two months, the FDA approved the droopy eyelid drug which pushed the stock higher. Then they made a secondary offering which didn't meet demand and the stock pulled back.
Pharma & Healthcare
DON'T BUY
A tiny company and speculative. Some months ago, they had a tired, but profitable portfolio of generic and profitable drugs that produced a stream of cash. They invested that cash to treat droopy eyelid, with a goal to be a less-generic drug company and more branded. Then they tested an MS-related drug, but shelved it which hurt the stock. Two months, the FDA approved the droopy eyelid drug which pushed the stock higher. Then they made a secondary offering which didn't meet demand and the stock pulled back.
Pharma & Healthcare
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Osmotica Pharmaceuticals (OSMT-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Osmotica Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Osmotica Pharmaceuticals (OSMT-Q) Frequently Asked Questions

What is Osmotica Pharmaceuticals stock symbol?

Osmotica Pharmaceuticals is a American stock, trading under the symbol OSMT-Q on the NASDAQ (OSMT). It is usually referred to as NASDAQ:OSMT or OSMT-Q

Is Osmotica Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of Osmotica Pharmaceuticals published on Stockchase.

Is Osmotica Pharmaceuticals a good investment or a top pick?

Osmotica Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Osmotica Pharmaceuticals .

Why is Osmotica Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Osmotica Pharmaceuticals worth watching?

In the last year, there was no coverage of Osmotica Pharmaceuticals published on Stockchase.

What is Osmotica Pharmaceuticals stock price?

On 2022-01-14, Osmotica Pharmaceuticals (OSMT-Q) stock closed at a price of $1.13.